Daiichi Sankyo, Inc.

dsi.com

Daiichi Sankyo, Inc. headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. and a member of the Daiichi Sankyo Group. Global clinical development and regulatory activities are headquartered at Daiichi Sankyo Pharma Development in Edison, New Jersey.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Digital Healthcare, Medical Devices

SOFWAVE MEDICAL ANNOUNCES FDA CLEARANCE OF SUPERB™ TECHNOLOGY FOR CELLULITE

SofWave Medical, Ltd. | December 20, 2022

news image

Sofwave Medical Ltd an emerging leader in energy-based non-invasive, aesthetic medical devices announced the U.S. Food and Drug Administration’s clearance of Sofwave’s SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite. Dr. Shimon Eckhouse, Chairman & Co-Founder commented on the occasion, “We are pleased to receive FDA clearance to use the Company's proprietary SUPERB™ technology to improve the appearance...

Read More

Future of Healthcare

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

news image

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More

Health Technology

FUSE MEDICAL, INC. ENTERS INTO MARKETING AGREEMENT WITH CAREPICS TELEHEALTH

Fuse Medical, Inc. | January 15, 2021

news image

Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Organization") an arising manufacturer and distributor of imaginative medical gadgets for the orthopedic and spine commercial center, reported today a concurrence with CarePICS, the most recent asset expansion to Fuse's extensive portfolio and biologics item contributions for wound consideration. Read More

Health Technology

ESSENTIA HEALTH SELECTS PRESS GANEY AS PATIENT EXPERIENCE AND NURSING EXCELLENCE PARTNER

pressganey | July 07, 2022

news image

Press Ganey, renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem announced it has entered into a multi-year agreement to provide technology, counsel and additional knowledge resources to Essentia Health, an integrated healthcare system serving patients in Minnesota, Wisconsin and North Dakota. Effective July 1, Press Ganey will support Essentia Health through rapid patient experience transformation and nursing excellence across the health syste...

Read More
news image

Digital Healthcare, Medical Devices

SOFWAVE MEDICAL ANNOUNCES FDA CLEARANCE OF SUPERB™ TECHNOLOGY FOR CELLULITE

SofWave Medical, Ltd. | December 20, 2022

Sofwave Medical Ltd an emerging leader in energy-based non-invasive, aesthetic medical devices announced the U.S. Food and Drug Administration’s clearance of Sofwave’s SUPERB™ technology to be used for the short-term improvement in the appearance of cellulite. Dr. Shimon Eckhouse, Chairman & Co-Founder commented on the occasion, “We are pleased to receive FDA clearance to use the Company's proprietary SUPERB™ technology to improve the appearance...

Read More
news image

Future of Healthcare

GENEQUANTUM AND AIMEDBIO COLLABORATE ON A FIRST-IN-CLASS ANTIBODY -DRUG-CONJUGATE

GeneQuantum Healthcare | April 19, 2022

GeneQuantum Healthcare Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic antibody drug conjugate (ADC). Aimed Bio, a spin-off company from Samsung Medical Center, is focusing on developing innovative antibody-centric drugs for brain diseases with few treatment options. Additional details were not disclosed. GeneQ...

Read More
news image

Health Technology

FUSE MEDICAL, INC. ENTERS INTO MARKETING AGREEMENT WITH CAREPICS TELEHEALTH

Fuse Medical, Inc. | January 15, 2021

Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Organization") an arising manufacturer and distributor of imaginative medical gadgets for the orthopedic and spine commercial center, reported today a concurrence with CarePICS, the most recent asset expansion to Fuse's extensive portfolio and biologics item contributions for wound consideration. Read More

news image

Health Technology

ESSENTIA HEALTH SELECTS PRESS GANEY AS PATIENT EXPERIENCE AND NURSING EXCELLENCE PARTNER

pressganey | July 07, 2022

Press Ganey, renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem announced it has entered into a multi-year agreement to provide technology, counsel and additional knowledge resources to Essentia Health, an integrated healthcare system serving patients in Minnesota, Wisconsin and North Dakota. Effective July 1, Press Ganey will support Essentia Health through rapid patient experience transformation and nursing excellence across the health syste...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us